Skip to main content
Clinical Trials/CTRI/2024/02/062647
CTRI/2024/02/062647
Not yet recruiting
Phase 4

Efficacy of continuous glucose monitoring for glycaemic control over standard treatment and monitoring in individuals with uncontrolled type 2 diabetes in Khordha district: A randomized control trial. - NI

Dr.Priyamadhabha Behera0 sites0 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Health Condition 1: E119- Type 2 diabetes mellitus without complications
Sponsor
Dr.Priyamadhabha Behera
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Dr.Priyamadhabha Behera

Eligibility Criteria

Inclusion Criteria

  • Individuals with type 2 diabetes on 3 or more oral antidiabetic agents with or without insulin HbA1C more than 7%.

Exclusion Criteria

  • Individuals with type 1 diabetes
  • Gestational diabetes mellitus
  • Individuals with diabetic complications (acute or chronic)
  • Individuals with a history of bleeding disorder
  • Individuals with a recent history of steroid use

Outcomes

Primary Outcomes

Not specified

Similar Trials